Medicare Advantage plans handle GLP-1 differently than original Medicare + Part D.
About this article
Reviewed byDr. J. Bottoni, M.D.
RoleEditor-in-Chief, Medicine
First publishedMay 20, 2026
Last reviewedMay 20, 2026
Page typeIn-depth editorial guide
Sources15+ cited sources
Original Medicare + Part D — April 2026 expansion
Wegovy now covered under SELECT-aligned CV pathway (BMI ≥27 + established CVD). T2D drugs (Ozempic, Mounjaro) covered.
Medicare Advantage variations
MA plans can have different formularies and supplemental benefits. Some MA plans cover weight management beyond the original Medicare scope.
How to evaluate plans
- Check formulary for Wegovy, Zepbound, Ozempic, Mounjaro.
- Review PA criteria.
- Calculate expected copay.
- Compare against cash-pay compounded ($1,740–$2,232/yr NexLife).